clinivation

  • Sign In
  • Contact
  • About
    • What We Do
    • Newsroom
    • Our Partners
    • Events
    • Careers
    • Contact
  • Solutions
    • Business Development
    • Clinical Operations
    • Commercial Operations
    • Health Policy & Reimbursement
    • Medical Affairs
    • Portfolio Management
    • Regulatory Affairs
    • Research & Development
  • Products
    • CareSite
    • ClinicalSuite
    • Cloud
    • Conformity
    • ForeSight
    • Global
    • Prospectus
    • RealWorld
    • RegistrySuite
    • ValueLogic
    • WorldView
  • Services & Support
    • Customer Support
    • Solution Services
    • CRO Services
    • Professional Services
    • Innovation Workshops
  • Resources
    • Data Sheets
  • Customers
    • Customer Success
Home / News / W.L. Gore Medical Selects the clinivation Global Enterprise Solution for Market Clearance Management
clinivation
CONTACT US

W.L. Gore Medical Selects the clinivation Global Enterprise Solution for Market Clearance Management

Provider of unique fluoropolymer technology solutions for products used in medicine, electronics, fabrics, cables, and sealants selects the clinivation Global Enterprise Solution for Market Clearance Management as the foundation for managing their global market clearance operations.

Natick, MA, February 13, 2009 – clinivation, Inc. announced today that W.L. Gore & Associates, Inc. has selected the the clinivation Global Enterprise Solution for Market Clearance Management enterprise solution for Market Clearance Management.

“W.L. Gore develops and produces remarkable and effective medical products such as wound healing materials, vascular interventional devices, and sutures to name a few and we are pleased that they have selected the clinivation Global xi Market Clearance Platform as the foundation for managing their global market clearance operations,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.

About the the clinivation Global Enterprise Solution for Market Clearance Management Market Clearance Platform

The the clinivation Global Enterprise Solution for Market Clearance Management enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, the clinivation Global Enterprise Solution for Market Clearance Management liberates revenue that’s trapped-in-process.

About W.L. Gore & Associates, Inc.

Headquartered in Newark, Delaware, W.L. Gore was established in 1958 by Bill and Vieve Gore with the goal of exploring the possibilities and capabilities for fluorocarbon polymers such as polytetrafluoroethylene (PTFE) in industrial and consumer products. Fifty-years later, W.L. Gore has a world-wide team of approximately 8,000 employers and has yearly revenue of about $2 billion.

Their unique fluoropolymers are used to manufacture innovative and high performance products in areas such as electronics, medicine, fabrics and fibers, medical devices, sealants, and venting. A few of the company’s most prominent consumer products include GORE-TEX® Outerwear, WINDSTOPPER® Outerwear, and ELIXIR® Strings. In the medical device arena, the company produces products for general surgery, orthopedics, tissue repair, and the treatment of aortic aneurysms and other vascular diseases.

FOURTUNE Magazine has consistently announced that W.L. Gore is among the “100 Best Companies to Work for in America.”

Share

About clinivation

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

Media Contact

Corporate Communications
irpr@clinivation.com

clinivation, Inc.
Suite 1800
245 First Street
Cambridge, MA 02142
U.S.A.
Phone +1 617‐444‐8500

About

  • What We Do
  • Newsroom
  • Our Partners
  • Events
  • Careers
  • Contact

Solutions

  • Business Development
  • Clinical Operations
  • Commercial Operations
  • Health Policy & Reimbursement
  • Medical Affairs
  • Portfolio Management
  • Regulatory Affairs
  • Research & Development

Products

  • CareSite
  • ClinicalSuite
  • Cloud
  • Conformity
  • ForeSight
  • Global
  • Prospectus
  • RealWorld
  • RegistrySuite
  • ValueLogic
  • WorldView

Services & Support

  • Customer Support
  • Solution Services
  • CRO Services
  • Professional Services
  • Innovation Workshops

Resources

  • Data Sheets

Customers

  • Customer Success
American Flag US: +1 (617) 444‐8500
Contact Us
  • Privacy
  • Terms Of Use
  • Trademarks
  • Site Map

© 2025 · clinivation, INC.

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly
connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions
that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

​